PR Newswire Transaction to enhance Labcorp’s laboratory services network and expand access to the company’s high-quality clinical laboratory services BURLINGTON, N.C. and MIAMI, March 28, 2024 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select […]
Category Archives: Press Release
Press Release
BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing
28
Nov
Nov
Elmwood Park, NJ – November 28, 2023 – BioReference® Health, LLC (BRH), a leading specialty laboratory in the United States, announced a strategic collaboration with Prognos Health, a pioneer in providing accessible, quality real world data (“RWD”) for the pharmaceutical and life science industries. This collaborative arrangement will offer healthcare providers and researchers unique solutions […]
Press Release
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™
07
Nov
Nov
World-class liquid biopsy testing will be made commercially available to BioReference® customers across the country BOSTON, MA, ELMWOOD PARK, NJ, and Rolle, Switzerland, November 7, 2023 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that BioReference® Health, LLC, an OPKO Health, Inc. company and full-service laboratory that […]
Press Release
BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings
09
Feb
Feb
CINtec® PLUS Cytology offered as a reflex test when cytology is NILM and HPV positive ELMWOOD PARK, NJ, February 9, 2023 – BioReference® Health LLC, one of the largest full-service specialty laboratories in the United States, announced today it will be one of the first commercial laboratories to use offer the CINtec® PLUS Cytology test from […]
Press Release
Aspira Women’s Health Announces Formal Launch of Co-Marketing and Distribution Collaboration with BioReference
05
Oct
Oct
Aspira Women’s Health Inc. OVA1Plus® now available to an expanded network of physicians, supporting patients nationwide AUSTIN, Texas, Oct. 05, 2022 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced the formal launch of its co-marketing and distribution collaboration with BioReference®, an OPKO Health […]
Press Release
Cue Health and BioReference Laboratories Bring Point-of-Care Solutions to the Clinical Setting
05
Apr
Apr
Cue Health debuts Cue Clinic™ dashboard to give healthcare providers more choice and control over patient care as part of BioReference’s product offering SAN DIEGO and ELMWOOD PARK, N.J., April 5, 2022 /PRNewswire/ — Cue Health Inc. (“Cue”) (Nasdaq: HLTH), the healthcare technology company behind one of the country’s most accurate COVID-19 tests and BioReference Laboratories, Inc., an OPKO Health company (“BioReference”), today announced […]
Press Release
BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S.
29
Nov
Nov
ELMWOOD PARK, N.J., November 29, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), announced COVID-19 testing preparedness for the Omicron Variant. BioReference’s PCR diagnostic tests for SARS-CoV-2 COVID-19 are based on recognizing specific RNA target genes that are common to all coronaviruses. To date, the diagnostic targets have not changed with the novel […]
06
Oct
Oct
ELMWOOD PARK, NJ and Chicago, IL (October 6, 2021) – BioReference Laboratories’ Richard Schwabacher is among Modern Healthcare’s 2021 class of Top 25 Emerging Leaders. Modern Healthcare, the leader in healthcare business news, research and data, annually honors emerging leaders all age 40 or under, who have made significant contributions in the areas of innovation […]
Press Release
Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces ‘Back to School’ COVID-19 Testing Program
26
Aug
Aug
New York students K-12 will have the opportunity for COVID-19 testing prior to or at the start of the 2021-2022 school year through Rite Aid and BioReference CAMP HILL, Pa. (August 26, 2021) – Rite Aid (NYSE: RAD) and the U.S. Department of Health and Human Services (HHS), together with BioReference Laboratories, Inc., an OPKO Health […]
Press Release
BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business
16
Aug
Aug
ELMWOOD PARK, N.J., August 16, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S. Ariosa centralized laboratory prenatal testing business from Roche. Ariosa’s non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, is one of the most widely studied tests utilized in prenatal screening. The test has been performed in […]
